Skip to content

The Analgesic Efficacy of the Pectoral Block After Mastectomy

The Analgesic Efficacy of the Pectoral Block After Mastectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02916381
Enrollment
50
Registered
2016-09-27
Start date
2017-01-31
Completion date
2019-04-30
Last updated
2019-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

Unilateral mastectomy is associated with moderate to severe postoperative pain. A new regional anaesthetic technique has been recently described, call the PEC block. This technique consists of injecting local anaesthetic between different muscles of the chest in order to relieve postoperative pain. The investigators aim to verify that this technique has a clinical relevant postoperative analgesic effect. For that purpose, the investigators will randomise 50 patients scheduled to undergo unilateral mastectomy into two groups: one group will receive a PEC block after the induction of the general anaesthesia under ultrasound guidance, while the other group will not have this regional procedure.

Interventions

PROCEDUREPEC block + General anaesthesia

Patients will receive an ultrasound-guided PEC block after the induction of general anaesthesia.

PROCEDUREGeneral anaesthesia

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ASA physical status I-III * Age ≥ 18 * Patients undergoing unilateral mastectomy

Exclusion criteria

* Contraindications to regional block * Pregnancy * Inability to give informed consent * History of alcohol or drug dependence/abuse * History of long term opioid intake or chronic pain disorder

Design outcomes

Primary

MeasureTime frame
Intravenous morphine consumption during the first 24 postoperative hours (mg)Postoperative day 1

Secondary

MeasureTime frameDescription
Intravenous morphine consumption on postoperative day 2 (mg)Postoperative day 2
Intravenous morphine consumption in phase 1 recovery (mg)2 postoperative hours
Pain scores at rest in phase 1 recovery (visual analogue scale, 0 - 10)2 postoperative hours(visual analogue scale, 0 - 10)
Pain scores at rest on postoperative day 1 (visual analogue scale, 0 - 10)Postoperative day 1Visual analogue scale, 0 - 10)
Pain scores at rest on postoperative day 2 (visual analogue scale, 0 - 10)Postoperative day 2Visual analogue scale, 0 - 10)
Postoperative nausea and vomiting (yes/no)Postoperative day 1
Pruritus (yes/no)Postoperative day 1

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026